|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 136 found articles
| Title: |
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial |
| Author: |
Voorhees, Peter M Sborov, Douglas W Laubach, Jacob Kaufman, Jonathan L Reeves, Brandi Rodriguez, Cesar Chari, Ajai Silbermann, Rebecca Costa, Luciano J Anderson Jr, Larry D Nathwani, Nitya Shah, Nina Bumma, Naresh Efebera, Yvonne A Holstein, Sarah A Costello, Caitlin Jakubowiak, Andrzej Wildes, Tanya M Orlowski, Robert Z Shain, Kenneth H Cowan, Andrew J Dinner, Shira Pei, Huiling Cortoos, Annelore Patel, Sharmila Lin, Thomas S Usmani, Saad Z Richardson, Paul G |
| Appeared in: |
The Lancet. Haematology |
| Paging: | Volume 10 () nr. 10 pages e825-e837 |
| Year: |
2023 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 136 found articles
| << previous | next >> |